Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed May 28, 2024 · 10-Q · 58 days after period end · 0001493152-24-021650
| Metric | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|
| Net Income | $11.26M | -$30.76M | -$25.99K |
| EPS Diluted | -$0.26 | -$0.26 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 28, 2024 · 58 d after period end
